RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0041-1734320
Pneumothorax in SARS-CoV-2 Affected Patients
Authors
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has various known complications in its natural course of the illness. Pneumothorax is one of the emerging complications in coronavirus disease 2019 (COVID-19)-positive patients, not initiated on invasive mechanical ventilation. Case studies and autopsy reports across the globe suggest alveolar pathology to be responsible for the outcome.
COVID-19 infection in humans caused by the SARS-CoV-2 virus has various known complications in its natural course of the illness. Pneumothorax is one of the emerging complications in COVID-19-positive patients. Prior identification and anticipation of such life-threatening complications aid in the treatment of COVID-19-positive patients.
Publikationsverlauf
Artikel online veröffentlicht:
18. August 2021
© 2021. Nitte (Deemed to be University). Nitte University. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol 2020; 215: 108427
- 2 Huang C, Wang Y, Li X. et al Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223) 497-506
- 3 Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr Probl Cardiol 2020; 45 (08) 100618
- 4 Lang M, Som A, Carey D, et al. Pulmonary vascular manifestations of COVID-19 Pneumonia: radiology. Cardiothoracic Imag 2020;2(3)
- 5 Xu Z, Shi L, Wang Y. et al Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8 (04) 420-422
- 6 Terzi E, Zarogoulidis K, Kougioumtzi I. et al Human immunodeficiency virus infection and pneumothorax. J Thorac Dis 2014; 6 (Suppl. 04) S377-S382
- 7 Sun R, Liu H, Wang X. Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia. Korean J Radiol 2020; 21 (05) 541-544
- 8 Martinelli AW, Ingle T, Newman J. et al COVID-19 and pneumothorax: a multicentre retrospective case series. Eur Respir J 2020; 56 (05) 2002697
- 9 Sihoe AD, Wong RH, Lee AT. et al Severe acute respiratory syndrome complicated by spontaneous pneumothorax. Chest 2004; 125 (06) 2345-2351
- 10 Zantah M, Dominguez Castillo E, Townsend R, Dikengil F, Criner GJ. Pneumothorax in COVID-19 disease- incidence and clinical characteristics. Respir Res 2020; 21 (01) 236
- 11 López Vega JM, Parra Gordo ML, Diez Tascón A, Ossaba Vélez S. Pneumomediastinum and spontaneous pneumothorax as an extrapulmonary complication of COVID-19 disease. Emerg Radiol 2020; 27 (06) 727-730
- 12 Carron M, Freo U, BaHammam AS. et al Complications of non-invasive ventilation techniques: a comprehensive qualitative review of randomized trials. Br J Anaesth 2013; 110 (06) 896-914